Search research articles
Contact Us
Filters
Showing results (41-50 of 67) with videos related to
Page
of 7
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
January 26, 2025
Nivolumab and hypofractionated radiotherapy in patients with advanced melanoma: A phase 2 trial
Jérôme Doyen, Anne Dompmartin, Coralie Cruzel, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
August 16, 2022
Human papilloma virus vaccine for palmoplantar warts: A retrospective study of 18 patients
Léa Merio, Johan Chanal, Marie Jachiet, et al.
Melanoma Research
|
March 30, 2023
Clostridium difficile infection and immune checkpoint inhibitor-induced colitis in melanoma: 18 cases and a review of the literature
Chloé Vuillamy, Jean-Philippe Arnault, Mathurin Fumery, et al.
Cancers
|
June 27, 2020
Combined Therapy with Anti-PD1 and BRAF and/or MEK Inhibitor for Advanced Melanoma: A Multicenter Cohort Study
Sandra Huynh, Laurent Mortier, Caroline Dutriaux, et al.
Pigment Cell & Melanoma Research
|
January 26, 2017
Metformin monotherapy in melanoma: a pilot, open-label, prospective, and multicentric study indicates no benefit
Henri Montaudié, Michael Cerezo, Philippe Bahadoran, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
September 6, 2022
Efficacy and Safety of Botulinum Toxin in Adults with Raynaud's Phenomenon Secondary to Systemic Sclerosis: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study
Patricia Senet, Hervé Maillard, Elisabeth Diot, et al.
JCO Precision Oncology
|
November 10, 2022
Non-V600E/K BRAF Mutations in Metastatic Melanoma: Molecular Description, Frequency, and Effectiveness of Targeted Therapy in a Large National Cohort
Manon Girod, Stéphane Dalle, Laurent Mortier, et al.
Frontiers in Oncology
|
November 8, 2023
Differential gradients of immunotherapy vs targeted therapy efficacy according to the sun-exposure pattern of the site of occurrence of primary melanoma: a multicenter prospective cohort study (MelBase)
David Russo, Stéphane Dalle, Olivier Dereure, et al.
Cancers
|
July 2, 2021
Tolerance and Effectiveness of Targeted Therapies in Aged Patients with Metastatic Melanoma
Ondine Becquart, Bastien Oriano, Stéphane Dalle, et al.
Journal of the American Academy of Dermatology
|
December 21, 2022
Impact of systemic therapies in metastatic melanoma of unknown primary: A study from MELBASE, a French multicentric prospective cohort
Perrine Rousset, Stéphane Dalle, Laurent Mortier, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 67) with videos related to
Sort By:
Page
of 7
European Journal of Cancer (Oxford, England : 1990)
|
January 26, 2025
Nivolumab and hypofractionated radiotherapy in patients with advanced melanoma: A phase 2 trial
Jérôme Doyen, Anne Dompmartin, Coralie Cruzel, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
August 16, 2022
Human papilloma virus vaccine for palmoplantar warts: A retrospective study of 18 patients
Léa Merio, Johan Chanal, Marie Jachiet, et al.
Melanoma Research
|
March 30, 2023
Clostridium difficile infection and immune checkpoint inhibitor-induced colitis in melanoma: 18 cases and a review of the literature
Chloé Vuillamy, Jean-Philippe Arnault, Mathurin Fumery, et al.
Cancers
|
June 27, 2020
Combined Therapy with Anti-PD1 and BRAF and/or MEK Inhibitor for Advanced Melanoma: A Multicenter Cohort Study
Sandra Huynh, Laurent Mortier, Caroline Dutriaux, et al.
Pigment Cell & Melanoma Research
|
January 26, 2017
Metformin monotherapy in melanoma: a pilot, open-label, prospective, and multicentric study indicates no benefit
Henri Montaudié, Michael Cerezo, Philippe Bahadoran, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
September 6, 2022
Efficacy and Safety of Botulinum Toxin in Adults with Raynaud's Phenomenon Secondary to Systemic Sclerosis: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study
Patricia Senet, Hervé Maillard, Elisabeth Diot, et al.
JCO Precision Oncology
|
November 10, 2022
Non-V600E/K BRAF Mutations in Metastatic Melanoma: Molecular Description, Frequency, and Effectiveness of Targeted Therapy in a Large National Cohort
Manon Girod, Stéphane Dalle, Laurent Mortier, et al.
Frontiers in Oncology
|
November 8, 2023
Differential gradients of immunotherapy vs targeted therapy efficacy according to the sun-exposure pattern of the site of occurrence of primary melanoma: a multicenter prospective cohort study (MelBase)
David Russo, Stéphane Dalle, Olivier Dereure, et al.
Cancers
|
July 2, 2021
Tolerance and Effectiveness of Targeted Therapies in Aged Patients with Metastatic Melanoma
Ondine Becquart, Bastien Oriano, Stéphane Dalle, et al.
Journal of the American Academy of Dermatology
|
December 21, 2022
Impact of systemic therapies in metastatic melanoma of unknown primary: A study from MELBASE, a French multicentric prospective cohort
Perrine Rousset, Stéphane Dalle, Laurent Mortier, et al.
Page
of 7